Regions of interest (ROIs) were selected at the periphery of the tumors where sympathetic fibers are normally located, and each ROI was segmented into immune-dominant and tumor-dominant regions based on CD45 and pan-cytokeratin immunofluorescent staining, respectively. Here, PTPRC is linked to neoplasm.